Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
SYRA - Syra Health Corp. - Stock Price Chart
TickerSYRA [NASD]
CompanySyra Health Corp.
CountryUSA
IndustryMedical Care Facilities
Market Cap20.61MEPS (ttm)-0.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.62EPS next 5Y-
P/B-EPS Q/Q-37.00%
Dividend-Sales Q/Q6.70%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.03%EarningsNov 14/b
Analyst Recom-Target Price-
Avg Volume37.89K52W Range1.05 - 3.70
Nov-30-23 09:00AM Syra Health Secures Contract to Provide Social Services in Kansas (PR Newswire) -5.51%
Nov-28-23 09:05AM Syra Health Corp announces company has launched a new digital health product SyraBot (News Direct) +9.84%
09:27AM Syra Health to provide Behavioral and Mental Health Screening and Evaluation Services to Law Enforcement Personnel in New Jersey (PR Newswire)
Nov-21-23 09:00AM Syra Health Secures Contract Worth More than a Quarter of a Million Dollars to Evaluate San Antonio's Racial and Ethnic Approaches to Community Health (REACH) (PR Newswire)
Nov-14-23 07:00AM Syra Health Announces Third Quarter 2023 Financial Results (PR Newswire)
Nov-13-23 09:00AM Syra Health Launches SyraBot, a digital health product (PR Newswire) -7.04%
Nov-09-23 09:00AM Syra Health To Discuss Third Quarter 2023 Financial Results (PR Newswire)
Nov-07-23 09:00AM Syra Health Secures Two-Year Contract to Assess and Implement Culturally and Linguistically Appropriate Services for Minnesota Department of Human Services (PR Newswire)
Nov-02-23 09:00AM Syra Health (NASDAQ: SYRA) Rings The NASDAQ Opening Bell (PR Newswire)
Oct-31-23 09:00AM Syra Health (Nasdaq: SYRA) to Ring The Nasdaq Stock Market Opening Bell on November 1 (PR Newswire) -6.03%
VIEW - View Inc. - Stock Price Chart
TickerVIEW [NASD]
CompanyView Inc.
CountryUSA
IndustryBuilding Products & Equipment
Market Cap7.37MEPS (ttm)-67.86
P/E-EPS this Y48.13%
Forward P/E-EPS next Y56.91%
PEG-EPS past 5Y-
P/S0.06EPS next 5Y-
P/B-EPS Q/Q-13786.02%
Dividend-Sales Q/Q60.85%
Insider Own33.26%Inst Own35.96%
Insider Trans-38.17%Inst Trans-58.21%
Short Float5.72%EarningsNov 14/a
Analyst Recom3.00Target Price180.00
Avg Volume1.10M52W Range0.62 - 95.40
Nov-15-23 09:33AM View, Inc. (NASDAQ:VIEW) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.90%
Nov-14-23 04:20PM RXR Selects View Smart Windows for 89 Dekalb Avenue in Brooklyn, NY, the Second RXR Multifamily Development to Feature View (GlobeNewswire) +33.08%
04:15PM View Announces Q3 2023 Earnings (GlobeNewswire)
Nov-09-23 07:00AM View to Release Third Quarter 2023 Financial Results Tuesday, November 14th (GlobeNewswire)
Oct-30-23 07:00AM View, Inc. Adds Tridium's Niagara to View Secure Edge Marketplace (GlobeNewswire) -14.02%
Oct-16-23 07:30AM View Announces $50 Million Financing with Strategic Real Estate Investors (GlobeNewswire)
Aug-10-23 04:15PM View Announces Q2 2023 Earnings (GlobeNewswire) -10.83%
04:10PM View Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Jul-31-23 08:29PM View to Release Second Quarter 2023 Financial Results Thursday, August 10th (GlobeNewswire) -27.78%
Jul-27-23 05:55AM View, Inc. Completes Reverse Stock Split (GlobeNewswire) +44.36%
VKTX - Viking Therapeutics Inc - Stock Price Chart
TickerVKTX [NASD, RUT]
CompanyViking Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.75BEPS (ttm)-0.92
P/E-EPS this Y-3.19%
Forward P/E-EPS next Y-17.22%
PEG-EPS past 5Y-2.56%
P/S-EPS next 5Y40.00%
P/B4.76EPS Q/Q-9.46%
Dividend-Sales Q/Q-
Insider Own10.64%Inst Own75.58%
Insider Trans0.00%Inst Trans-0.34%
Short Float18.98%EarningsOct 25/a
Analyst Recom1.09Target Price33.80
Avg Volume2.15M52W Range3.54 - 25.72
Dec-03-23 04:14PM Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer Here Are 2 Stocks to Take Advantage (TipRanks)
Nov-13-23 04:02PM Viking Therapeutics Presents New Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) at The Liver Meeting 2023 (PR Newswire)
Nov-09-23 08:48AM Q3 2023 Ligand Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -5.85%
Nov-04-23 07:30AM 1 Under-the-Radar Stock That Could Triple By 2030 (Motley Fool)
Nov-02-23 04:03PM Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Oct-27-23 01:05PM Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 11:22AM Q3 2023 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -9.42%
Oct-25-23 06:25PM Viking Therapeutics Inc (VKTX) Reports Q3 2023 Financial Results (GuruFocus.com)
04:05PM Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
Oct-23-23 07:05AM Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity (PR Newswire)
VVOS - Vivos Therapeutics Inc - Stock Price Chart
TickerVVOS [NASD]
CompanyVivos Therapeutics Inc
CountryUSA
IndustryMedical Devices
Market Cap18.96MEPS (ttm)-14.70
P/E-EPS this Y55.85%
Forward P/E-EPS next Y59.76%
PEG-EPS past 5Y-18.88%
P/S1.31EPS next 5Y-
P/B411.24EPS Q/Q72.68%
Dividend-Sales Q/Q-22.26%
Insider Own16.80%Inst Own14.95%
Insider Trans24.00%Inst Trans-10.29%
Short Float3.85%EarningsNov 14/a
Analyst Recom1.00Target Price6.00
Avg Volume1.07M52W Range2.73 - 74.05
Nov-30-23 08:51AM Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today? (InvestorPlace) -40.24%
01:20AM Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea (MedTech Dive)
Nov-29-23 01:04PM Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea (News Direct) +833.94%
11:56AM Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today? (InvestorPlace)
08:07AM UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea (Reuters)
07:39AM US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea (Reuters)
07:30AM Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea (GlobeNewswire)
Nov-14-23 04:05PM Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +9.71%
Nov-09-23 04:30PM Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call (GlobeNewswire) -11.55%
Nov-03-23 01:51PM Vivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare (News Direct) -5.52%
MLGO - MicroAlgo Inc - Stock Price Chart
TickerMLGO [NASD]
CompanyMicroAlgo Inc
CountryChina
IndustrySoftware - Infrastructure
Market Cap16.18MEPS (ttm)0.01
P/E254.76EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.94EPS Q/Q-225.44%
Dividend-Sales Q/Q-
Insider Own93.69%Inst Own2.26%
Insider Trans0.00%Inst Trans-0.09%
Short Float44.83%Earnings-
Analyst Recom-Target Price-
Avg Volume1.71M52W Range1.12 - 71.50
Sep-22-23 08:00AM MicroAlgo Inc. Announced Knowledge-enhanced Backtracking Search Algorithm (PR Newswire) +20.70%
Aug-11-23 06:08AM MicroAlgo Second Quarter 2023 Earnings: CN¥0.64 loss per share (vs CN¥0.032 profit in 2Q 2022) (Simply Wall St.) +8.07%
Jan-13-23 08:30AM MicroAlgo Inc. Announces Enters Securities Purchase Agreement for up to US$3.2 Million (PR Newswire)
Jan-08-23 08:51AM MicroAlgo (NASDAQ:MLGO) Could Be Struggling To Allocate Capital (Simply Wall St.)
SSNT - SilverSun Technologies Inc - Stock Price Chart
TickerSSNT [NASD]
CompanySilverSun Technologies Inc
CountryUSA
IndustrySoftware - Application
Market Cap48.39MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y13.07%
P/S0.93EPS next 5Y-
P/B6.86EPS Q/Q-1438.31%
Dividend-Sales Q/Q22.96%
Insider Own41.50%Inst Own16.01%
Insider Trans-0.19%Inst Trans10.98%
Short Float1.77%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume662.26K52W Range2.54 - 13.37
Today 09:12AM Why Is SilverSun Technologies (SSNT) Stock Down 28% Today? (InvestorPlace) -26.34%
Dec-04-23 04:44PM Why Is SilverSun Technologies (SSNT) Stock Up 200% Today? (InvestorPlace) +240.33%
09:43AM Jacobs leading takeover of software company as he readies next move (FreightWaves)
07:00AM Brad Jacobs to Lead Equity Investment of $1 Billion in SilverSun Technologies and Pursue Acquisitions in an Industry to be Announced Later (ACCESSWIRE)
Nov-15-23 09:00AM SilverSun Technologies Acquires JCS Computer Resource Corporation (ACCESSWIRE)
Nov-14-23 09:40AM CORRECTION BY SOURCE: Silversun Technologies Reports Third Quarter 2023 Results (ACCESSWIRE)
08:40AM SilverSun Technologies Reports Third Quarter 2023 Results (ACCESSWIRE)
Sep-26-23 01:00PM SWK Technologies and eCommerce Software Trio Launch Educational Series (ACCESSWIRE)
Aug-25-23 11:39AM Is SilverSun Technologies Stock Fairly Valued? (GuruFocus.com)
Aug-10-23 06:10AM SilverSun Technologies, Inc.'s (NASDAQ:SSNT) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? (Simply Wall St.) +5.01%
HTOO - Fusion Fuel Green Ltd - Stock Price Chart
TickerHTOO [NASD]
CompanyFusion Fuel Green Ltd
CountryIreland
IndustryUtilities - Renewable
Market Cap17.90MEPS (ttm)-2.14
P/E-EPS this Y39.27%
Forward P/E-EPS next Y34.43%
PEG-EPS past 5Y-250.08%
P/S5.34EPS next 5Y-
P/B0.53EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own13.77%Inst Own22.87%
Insider Trans0.00%Inst Trans-
Short Float2.17%EarningsDec 04/b
Analyst Recom2.33Target Price2.82
Avg Volume222.51K52W Range0.50 - 6.60
Dec-04-23 06:10AM Fusion Fuel Green Hosts Third Quarter 2023 Investor Update (GlobeNewswire) +11.82%
Nov-30-23 04:00AM Fusion Fuel Receives Purchase Order for 1.25 MW HEVO-Chain Electrolyzer (GlobeNewswire) -15.24%
Nov-27-23 06:00AM Fusion Fuel Green Announces Strategic Tranched Financing from Belike Nominees Pty Ltd., a Macquarie Group Company (GlobeNewswire) +44.94%
Nov-21-23 04:00AM Fusion Fuel Announces Third Quarter 2023 Webcast Date (GlobeNewswire) -5.35%
Nov-08-23 04:00AM Fusion Fuel Receives Purchase Order from Portuguese Energy Company for 1.25 MW Electrolyzer Facility (GlobeNewswire)
Nov-07-23 04:30PM Fusion Fuel Green Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement (GlobeNewswire) -8.61%
Sep-27-23 03:00AM Fusion Fuel Receives Purchase Order for 300 kW Electrolyzer and Balance of Plant System from Leading Global Building Solutions Supplier (GlobeNewswire)
Sep-14-23 10:33AM Elemental Clean Fuels partners with Piney Point Capital and Fusion Fuel to advance Decarbonization Projects in North America (GlobeNewswire) +9.57%
09:00AM Fusion Fuel Announces Strategic Partnership with Elemental Clean Fuels, Strengthens Foothold in North American Green Hydrogen Market (GlobeNewswire)
Aug-30-23 06:15AM Fusion Fuel Green Hosts Second Quarter 2023 Investor Update (GlobeNewswire) -17.24%
AMPE - Ampio Pharmaceuticals Inc - Stock Price Chart
TickerAMPE [AMEX]
CompanyAmpio Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.10MEPS (ttm)-12.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y34.16%
P/S-EPS next 5Y-
P/B0.38EPS Q/Q82.04%
Dividend-Sales Q/Q-
Insider Own9.68%Inst Own0.33%
Insider Trans139.93%Inst Trans-28.81%
Short Float2.06%Earnings-
Analyst Recom1.00Target Price600.00
Avg Volume353.76K52W Range1.86 - 8.30
Nov-01-23 07:00AM Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now (GlobeNewswire)
Oct-31-23 09:00AM Ampio Pharmaceuticals to Present at the Emerging Growth Conference (PR Newswire)
Oct-05-23 04:30PM Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 (PR Newswire)
Oct-04-23 07:00AM Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now (GlobeNewswire)
Oct-03-23 07:00AM Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now (GlobeNewswire)
Sep-26-23 09:15AM Ampio Pharmaceuticals to Present at the Emerging Growth Conference (PR Newswire) -5.64%
Aug-31-23 06:30AM Ampio Pharmaceuticals Announces Reverse Stock Split (PR Newswire) +10.86%
May-26-23 04:40PM Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock (PR Newswire)
Apr-18-23 06:30AM AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS (PR Newswire) +22.19%
Jan-17-23 08:20AM AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS (PR Newswire) -7.28%
REPL - Replimune Group Inc - Stock Price Chart
TickerREPL [NASD, RUT]
CompanyReplimune Group Inc
CountryUSA
IndustryBiotechnology
Market Cap377.99MEPS (ttm)-3.20
P/E-EPS this Y-17.40%
Forward P/E-EPS next Y-5.37%
PEG-EPS past 5Y-37.07%
P/S-EPS next 5Y-
P/B0.81EPS Q/Q-14.59%
Dividend-Sales Q/Q-
Insider Own26.61%Inst Own86.58%
Insider Trans-0.49%Inst Trans-0.85%
Short Float17.01%EarningsNov 07/b
Analyst Recom1.11Target Price48.44
Avg Volume801.10K52W Range9.79 - 29.52
Today 07:32AM UPDATE 1-Replimune's skin cancer drug fails in mid-stage study (Reuters) -48.05%
07:10AM CORRECTED-Replimune's skin cancer drug fails in mid-stage study (Reuters)
07:00AM Replimune Shares Initial Primary Analysis Results from CERPASS Clinical Trial in Advanced Cutaneous Squamous Cell Carcinoma and Presents New Data from IGNYTE Clinical Trial of RP1 in Anti-PD1 Failed Melanoma and Non-Melanoma Skin Cancers (GlobeNewswire)
Nov-13-23 09:55AM Forbion co-leads 129 million Series A financing of VectorY, one of the largest private biotech financings in Europe in 2023 (GlobeNewswire)
Nov-08-23 09:10AM Replimune Presents Updated Data on RP2 in Uveal Melanoma during Plenary Session at the 20th International Congress of the Society for Melanoma Research (GlobeNewswire) +6.56%
Nov-07-23 08:00AM Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -15.85%
Nov-03-23 07:30PM Replimune Presents Updated Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers During Oral Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire)
Oct-17-23 03:00AM Tessellate BIO Emerges from Stealth (GlobeNewswire)
Sep-19-23 04:01PM Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM Replimune Announces Appointment of Emily Hill as Chief Financial Officer (GlobeNewswire)
GSIW - Garden Stage Limited Ordinary Shares - Stock Price Chart
TickerGSIW [NASD]
CompanyGarden Stage Limited Ordinary Shares
CountryHong Kong
IndustryAsset Management
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.80M52W Range4.20 - 11.70
Dec-01-23 11:43AM Garden Stage Limited Announces Pricing of Initial Public Offering (GlobeNewswire)
12345678910⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.